When Is Door-to-Balloon Time Critical?: Analysis From the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trials

Abstract
No abstract available
Funding Information
  • Cardiovascular Research Foundation
  • Boston Scientific and the Medicines Company
  • Guidant Corporation
  • Lilly Research Laboratories
  • Boston Scientific
  • Medtronic
  • LightLab
  • Abbott Vascular
  • Abbott Vascular
  • The Medicines Company
  • Bristol-Myers Squibb/Sanofi and Bracco

This publication has 11 references indexed in Scilit: